Lexology July 29, 2024
Taft Stettinius & Hollister LLP

On June 28, 2024, the Supreme Court of the United States overruled longstanding “Chevron deference” in Loper Bright Enterprises v. Raimondo, 603 U.S. ___, No. 22-45 (2024) and Relentless, Inc. v. Department of Commerce No. 22-1219, changing the way courts will review disputes involving interpretation of statutes and agency rules. While much has now changed, the true effects of these rulings in the health care industry will be seen as courts begin issuing decisions to resolve disputes arising from conflicting interpretations of health care statutes — such as the interpretation by the Centers for Medicare and Medicaid Services (CMS) — without deference to the agency.

This law bulletin summarizes Chevron, the new Supreme Court ruling, and implications for the health...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Regulations
Google, Meta execs blast Europe over strict AI regulation as Big Tech ups the ante
AI Regulations: EU Withdraws AI Liability Proposal; US Seeks Comments on AI Action Plan
Europe risks becoming a 'museum' if it doesn't innovate in AI and deregulate, Swedish PM warns
What A New Presidency Means For Global Cybersecurity—And For SMEs
Lack of regulations, oversight in health care IT can cause harm

Share This Article